drugset / Trial / NCT00671567
Ramelteon in Adults With Chronic Insomnia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of Ramelteon, once daily (QD), in adult subjects with chronic insomnia.
Timeline
- Start
- 2002-12
- Primary completion
- 2003-09
- Completion
- 2003-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramelteon | Unknown | 8 mg | Oral |
| Subject | Ramelteon | Unknown | 16 mg | Oral |